by Kenjiro Lolling | Jan 30, 2025 | News
Leiden, January 30th — The Stichting LBSP (Leiden Bio Science Park Foundation) is proud to announce the partnership with 360Pharma, supported by the Career Lab initiative, to launch an advanced talent portal on the 16th March 2025. This platform is set to...
by Kenjiro Lolling | Jan 28, 2025 | News
Improving Drug Discovery with Natural Flow Conditions OrganoPlate UF enables physiologically relevant tissue models by using unidirectional, gravity-driven flow, removing the need for external pumps. This approach simplifies operation while maintaining biological...
by Kenjiro Lolling | Jan 22, 2025 | News
Advancing Multi-Species In Vitro Assays During phase 2, Toxys will continue to develop and refine multi-species (human, rat, and rabbit) in vitro assays to predict in vivo teratogenicity. The team will qualify these assays using positive and negative reference...
by admin | Jan 22, 2025 | News
Leiden Bio Science Park Director Esther Peters joined Gerry van Bakel on Sleutelstad ‘s Kennismakers to discuss the park’s role in shaping The Future of Health. The conversation dove into boosting growth in one of Europe’s most dynamic life sciences hubs....
by Kenjiro Lolling | Jan 21, 2025 | News
Pharming Group has nominated Fabrice Chouraqui as the successor to CEO Sijmen de Vries. His appointment will be subject to approval at an Extraordinary General Meeting of Shareholders (EGM). Upon his appointment, Chouraqui will join the Board of Directors, while De...
by Kenjiro Lolling | Jan 21, 2025 | News
Toxys and Unilever have joined forces to advance New Approach Methodologies (NAMs) for assessing cellular stress—an essential factor in Next Generation Risk Assessment (NGRA). This collaboration aims to refine non-animal testing approaches by validating ToxProfiler,...